HomeALXO • NASDAQ
add
ALX Oncology Holdings Inc
Previous close
$16.62
Day range
$15.21 - $17.13
Year range
$3.94 - $17.47
Market cap
775.66M USD
Avg Volume
579.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 48.02M | 49.05% |
Net income | -45.47M | -48.07% |
Net profit margin | — | — |
Earnings per share | -0.79 | -4.94% |
EBITDA | -47.82M | -48.89% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 182.74M | -31.36% |
Total assets | 242.55M | -20.86% |
Total liabilities | 52.84M | 22.81% |
Total equity | 189.71M | — |
Shares outstanding | 50.15M | — |
Price to book | 4.37 | — |
Return on assets | -51.90% | — |
Return on capital | -61.46% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -45.47M | -48.07% |
Cash from operations | -39.68M | -91.98% |
Cash from investing | -16.67M | -252.31% |
Cash from financing | 59.17M | 523.19% |
Net change in cash | 2.82M | 1,316.38% |
Free cash flow | -20.18M | -127.44% |
About
Founded
2015
Headquarters
Website
Employees
72